Breast Lesions
9
0
0
2
Key Insights
Highlights
Success Rate
40% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
33.3%
3 terminated out of 9 trials
40.0%
-46.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers
Single Step Lesion Annotation and Localization of Suspicious Breast Lesions
Magseed Magnetic Marker Localization
Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms
A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)
Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)
Visualization Tool for Investigation of Breast Lesions
Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
Angiogenesis in Early Breast Cancer for Prognosis Prediction